Filter posts

T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets

New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming …

New PhRMA report: Nearly 800 Cancer Medicines in Development

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) shows that biopharma …

The Hill: In War on Cancer, Patients at Risk of Becoming Commoditized

Ted Okon, executive director of the Community Oncology Alliance, highlights the significant progress the medical …

Mito What???

Mitochondrial Disease: The Most Common Disease You’ve Probably Never Heard of… About 20 years ago, …

Playing Detective With Checkpoint Therapies

Three words are on the lips of everyone following new developments in cancer therapies: checkpoint inhibitor …

Decoding Genes to find Breast Cancer

Today, August 7, 2014, researchers at the University Medical Center Utrecht announced that they have identified a …

We Are the Worldview

Now in its 6th consecutive year, Scientific American Worldview: A Global Biotechnology Perspective will have …

Integrate and Collaborate to Drive Advancements in Oncology Treatments

Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry’s understanding of cancer, …

Forbes: Sure, We'll (Eventually) Beat Cancer. But Can We Afford To?

On May 19, Paul Howard highlighted the promise of immunotherapy for the treatment and possible …

Immuno Oncology - A 30-year Overnight Success Story

“It was the Rodney Dangerfield space – couldn’t get no respect” One would never guess …